LH2022 offline

General Information

Overview

The role of luteinizing hormone (LH) during folliculogenesis has intrigued the scientific and medical community for at least three decades. There is an emerging galaxy of research

to explore concerning this enigmatic subject. The availability of recombinant drugs now offers, for the first time, the opportunity to examine the role of follicle stimulating hormone and LH separately. An emerging topic during last year’s conference was LH supplementation to improve the outcome in a subgroup of low prognosis patients selected according to POSEIDON classification.

 

During this conference we will discuss the management of these low prognosis patients in greater detail. Notably, we will move beyond controlled ovarian stimulation to explore further the involvement of LH in personalizing the luteal phase and in male infertility. Also, on the agenda will be the extra-gonadal effect of LH, including potential immune-modulation at the endometrium.

 

Following the precedent set at last year’s conference, considerable time will be devoted to basic science, alongside such controversial issues as progesterone rise and pharmacogenomics. This year we have attracted prominent scientists from the worlds of endocrinology, andrology, immunology and embryology to take part in our engaging exploration of the LH galaxy.

Learning Objectives

After attending the educational activities, learners will be able to:

  • Understand the importance of luteinizing activity during folliculogenesis and beyond.
  • Understand the dynamics of hypothalamic-pituitary axis in the pathogenesis of hypo- and normo-gonadotropic amenorrhea.
  • Comprehend the concept of relative gonadotropin deficiency.
  • Discuss and debate the management of low prognosis patients.
  • Comprehend the clinical utility of LH supplementation to patients classified according to the POSEIDON criteria.
  • Discover the clinical relevance of LH supplementation in ART.
  • Analyse the relevance of LH during the luteal phase and introduce the concept of individualized luteal phase support.
  • Explore the potential role of LH in male infertility treatment.

Target Audience

This programme is designed for clinicians and biologists working in assisted reproductive medicine, who want to acquire up-to date information to improve their current practice.

Accreditation

This programme will be submitted for CME accreditation to EACCME® (European Accreditation Council for Continuing for Medical Education).

Venue

Hotel Royal Continental
Naples, Italy

Chairs

alviggi

Carlo Alviggi

Naples, Italy

fisher-small

Robert Fischer

Hamburg, Germany

esteves-small

Sandro C. Esteves

Campinas, Brazil

humaidan-small

Peter Humaidan

Aarhus University

Faculty

C. Alviggi – Italy

S. Esteves – Brazil

R. Fischer – Germany

P. Humaidan – Denmark

F. M. Ubaldi – Italy

E. Bosch – Spain

A. Baerwald – Canada

A. La Marca – Italy

D. Cesarini – USA

H. Yarali – Turkey

S. Sunkara – UK

M. Mochtar – The Netherlands

A. Conforti – Italy

K. Buhler – Germany

N. Polyzos – Spain

F. G. Klinger – Italy

R. Orvieto – Israel

Preliminary Programme

Friday, 27 May 2022

 

13:00
Registration and welcome lunch

 

14.00
MedEA Welcome
Robert Fischer, Germany

 

14.10
Local welcome
To be defined

 

14.30
Introduction and objectives
Voting system
Carlo Alviggi, Italy

 

Session I

Moving away from earth: lessons from gonadotropins system

Chairs: F. Ubaldi, Italy – E. Bosch, Spain

 

15.00
L1      Follicular waves
Baerwald, Canada

 

15.20
L2     Folliculogenesis and hormones
La Marca, Italy

 

15.40
Discussion

 

16.10
Coffee break

Session II

Chairs: M. Simoni, Italy; Sesh Sunkara, UK

 

16.30
L3     FSH and LH deficiency: new insights in stratifying patients (advanced maternal age polymorphisms)
Carlo Alviggi, Italy

 

16.50
L4     Hypothalamic amenorrhea and PCOS: two sides of the moon (not scholastic way)
A. Colao, Italy

 

17.10
L5     Role of LH in male infertility treatment
Sandro Esteves

 

17.30
Discussion – Voting system

 

18.00
Concluding remarks of the day

Saturday, 28 May 2022

 

09.00
Introduction day 2 and Voting system

 

Session III

LH in COS: the general population

Chairs:  Peter Humaidan, Denmark ; Hakan Yaraly, Turkey

 

9.20
L6     Defining endpoints
Sunkara, UK

 

9.40
L7     The state of the art according to EBM
Mochtar, The Netherlands

 

10.00
Discussion

 

10.20
Coffee Break

Session IV

LH in COS for low prognosis patients: The role of classification systems

Chairs: R. Fischer, Germany – C. Alviggi, Italy

 

10.40
L8     Capability of Bologna criteria to discriminate low prognosis patients
Yarali, Turkey

 

11.00
L9     Esteves Capability of Poseidon criteria to discriminate low prognosis patients
Sandro Esteves, Brazil

 

11.20
L10     Humaidan LH in poor responders according to Bologna and Poseidon criteria
Peter Humaidan, Denmark

 

11.40
L11     LH in advanced maternal age and hypo-responders
Alessandro Conforti, Italy

 

12.00
Discussion

 

12.30
Lunch

Session V


LH before and after COS

Chairs: K. Buhler, Germany; Antonio La Marca, Italy

 

14.00
L12     LH and androgens for improving ovarian reserve
Polyzos, Spain

 

14.20
L13     LH in triggering
Orvieto, Israel

 

14.40
L14     LH luteal phase support
Peter Humaidan, Denmark

 

15.00
L15     LH across COSs: The Duo-Stim
TBD

 

15.20
Discussion

 

15.40
Coffee break

Session VI

LH out ART

 Chairs: Carlo Alviggi, Italy; Sandro C. Esteves, Brazil

 

16.00
L16     New insights in LH anti-apoptotic activity
Cesarini, USA

 

16.20
L17     LH in fertility preservation
G. Klinger, Italy

 

16.40
L18     LH in immunology (extra-gonadal activity)
Tbd

 

17.00
Discussion

17.00
Voting System and concluding remarks

Preliminary Programme PDF

Coming Soon

General Information

Language

The official language of this live educational conference will be English.

CME Provider

Med.E.A – Medical Education Academy

Chloe Xilinas: Programme and Relations Manager in Medical Education
chloe.xilinas@medea.academy

Registration

To pre-register now enter: www.lh2022.education

For registration information please contact:
EVENT PLANET SRL

info@eventplanetgroup.com